PCVX

Vaxcyte (PCVX)

About Vaxcyte (PCVX)

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Details

Daily high

$56.69

Daily low

$55.00

Price at open

$55.67

52 Week High

$85.57

52 Week Low

$27.66

Market cap

7.8B

Dividend yield

0.00%

Volume

289,543

Avg. volume

1.8M

P/E ratio

-11.16

Vaxcyte News